Zobrazeno 1 - 10
of 11
pro vyhledávání: '"R A, Vukovich"'
Autor:
E S Neiss, Samm T. Portelli, R A Vukovich, P E Grebow, N C Tantillo, E P Barry, J A Treitman, D J Blasucci
Publikováno v:
European Journal of Clinical Pharmacology. 22:295-299
Two formulations of indapamide tablets (2.5 mg) were given as a 5.0 mg dose and the subsequent blood levels were compared to those obtained after administration of a 5.0 mg solution. The study was conducted as a randomized three-way crossover design
Autor:
John H. Barton, Martin Zisblatt, R. A. Vukovich, Neiss Es, Edmund L Webb, W E Schotz, J Eff, F Caruso, R Bronstein, M Losi
Publikováno v:
Current Medical Research and Opinion. 8:109-122
Indapamide, a new indoline antihypertensive agent, has been the subject of a worldwide programme to develop this drug for general clinical use. The results are described of the multi-centre U.S. clinical programme demonstrating the effectiveness and
Autor:
F. E. Hatch, B. I. Friedman, L. Share, C. F. Blackwell, J. G. Johnson, R. E. Shade, E. E. Muirhead, R. A. Vukovich, A. N. Shenouda, W. D. Black, S. R. Acchiardo
Publikováno v:
Clinical Science. 48:53s-56s
1. The results of the administration of the nonapeptide inhibitor (SQ 20,881) of the enzymatic conversion of angiotensin I into angiotensin II in twelve severe hypertensive patients are presented. 2. Administration of the compound was associated with
Publikováno v:
Annals of allergy. 51(5)
Three subjects diagnosed as having idiopathic acquired cold urticaria were studied to assess the ability of orally administered tiaramide to inhibit the wheal induced following cold challenge with ice cubes placed in contact with the skin, and to est
Publikováno v:
Annals of allergy. 51(3)
The ability of tiaramide hydrochloride (RHC 2592) to inhibit cutaneous reactivity was studied using 11 normal volunteers. After repeated administration tiaramide hydrochloride inhibited cutaneous mast cell mediator release induced by compound 48/80 w
Publikováno v:
Clinical therapeutics. 5(3)
This study, carried out in three centers in the United States, investigated the antihypertensive effect of three dosages of indapamide in 87 patients with mild to moderate hypertension. The dosages studied were 1 mg, 2.5 mg, and 5 mg daily. A double-
Publikováno v:
Current therapeutic research, clinical and experimental. 18(5)
Publikováno v:
Clinical therapeutics. 6(6)
A multicenter, double-blind, parallel-group study of 219 patients with pitting edema of various causes was undertaken to determine the efficacy and safety of indapamide, administered orally (PO) in a 2.5-, 5-, or 10-mg once-daily dose, as compared wi
Publikováno v:
The Journal of reproductive medicine. 21(3)
The passage of two antibiotics, cephradine and epicillin, into the milk of 12 lactating women and the amniotic fluid of 48 pregnant women was investigated. All women were given a 500-mg capsule every six hours for at least two days prior to our takin
Autor:
R A, Vukovich
Publikováno v:
Current therapeutic research, clinical and experimental. 18(5)